newsfilter
← Latest News
Business Wire·

Bristol Myers Squibb Announces Evolution of Research & Development Organization

  • Bristol Myers Squibb announced Cristian Massacesi will lead a unified Research & Development organization effective January 1, 2027.
  • Robert Plenge will serve in an advisory capacity until March 2027 to ensure a seamless transition before departing the company.
  • The new structure aims to merge scientific and clinical expertise to accelerate decision-making, enhance portfolio execution, and integrate new technologies.
  • Christopher Boerner stated the organizational change is designed to attract talent, build critical capabilities, and position the company for long-term growth.
  • Cristian Massacesi emphasized that uniting the teams will enable faster translation of discoveries into medicines for patients.
  • Robert Plenge expressed pride in past accomplishments, noted his partnership with Massacesi in designing the new structure, and confirmed confidence in the path forward.
  • The unified R&D organization will strengthen collaboration across the entire pipeline from discovery through development.